These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 663599)

  • 1. [Concerning the article: "A propos of 4 cases of potassium enteropathy" by H. Diserens, Ph. Gertsch, S. Schneider and R. Mosimann, Schweiz. med. Wschr. 107 1195-8 (1977)].
    Denereaz A; Vandierendounck E
    Schweiz Med Wochenschr; 1978 Jul; 108(27):1041. PubMed ID: 663599
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
    Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
    Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for the removal of an enteric-coated slow-release potassium preparation from the market in France.
    Trechot P; Netter P; Moore N; Vidrequin A; Boissel P; Voltz C
    Am J Gastroenterol; 1990 Mar; 85(3):330-1. PubMed ID: 2309690
    [No Abstract]   [Full Text] [Related]  

  • 4. Blends of reverse enteric polymer with Enteric and pH-independent polymers: mechanistic investigations for tailoring drug release.
    Menjoge AR; Kulkarni MG
    Biomacromolecules; 2007 Jan; 8(1):240-51. PubMed ID: 17206813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concerning: "Inhalation anthrax in a textile worker. A non-fatal course" (H. Winter and R.M. Pfisterer, Schweiz. med. Wschr. 1991; 121: 832-835)].
    Velimirović B
    Schweiz Med Wochenschr; 1992 Mar; 122(12):442. PubMed ID: 1557624
    [No Abstract]   [Full Text] [Related]  

  • 6. [Absorption of the drug-contents of enteric-coated tablets].
    Tikkanen R
    Nord Med; 1967 Nov; 78(47):1564-7. PubMed ID: 6075282
    [No Abstract]   [Full Text] [Related]  

  • 7. Ulcerogenic properties of enteric coated compounds in dogs.
    Stahlgren LH; Dapena A; Roy RL
    Surg Forum; 1965; 16():367-8. PubMed ID: 5888407
    [No Abstract]   [Full Text] [Related]  

  • 8. [Concerning: K. R. Beretta, R. Güller, M. Singeisen. G. A. Stalder: "Occult blood in the feces--a prospective study for the comparison of Haemoccult and Fecatest" Schweiz. med. Wschr. 108 1905-7 (1978)].
    Adlercreutz H; Liewendahl K; Virkola P
    Schweiz Med Wochenschr; 1979 May; 109(20):762-3. PubMed ID: 451502
    [No Abstract]   [Full Text] [Related]  

  • 9. [Concerning: Weihe W. H. : Animal protection and animal experiment from the viewpoint of biomedical research. Schweiz. med. Wschr. 109, 1577-1583 (1979)].
    Bleuler M
    Schweiz Med Wochenschr; 1980 Mar; 110(9):347. PubMed ID: 7367854
    [No Abstract]   [Full Text] [Related]  

  • 10. [Potassium chloride-containing drugs].
    Hilden T
    Ugeskr Laeger; 1970 Jul; 132(30):1407-8. PubMed ID: 5450797
    [No Abstract]   [Full Text] [Related]  

  • 11. [Concerning: Bernoulli R., Engelhart G., Velvart J.: "Peroral poisoning with isocyanate and methylenechloride." Schweiz. med. Wschr. 108, 866-868 (1978)].
    Lachnit V
    Schweiz Med Wochenschr; 1979 Jan; 109(2):60. PubMed ID: 424718
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of ranitidine and famotidine on the intragastric pH profile of healthy subjects. Randomized cross-over trial with ranitidine effervescent tablets (300 mg) versus famotidine film tablets (40 mg) ].
    Löser C; Burlage M; Fölsch UR
    Arzneimittelforschung; 1994 May; 44(5):626-9. PubMed ID: 8024636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Manufacturing delayed action tablet using sugar cane wax].
    Orbán E; Isaura LV
    Acta Pharm Hung; 1973 Jan; 43(1):9-13. PubMed ID: 4687825
    [No Abstract]   [Full Text] [Related]  

  • 14. [Peroral, compounded long-acting drugs. 3. Tablets coated with Eudragite retard].
    Chalabala M; Starha L
    Cesk Farm; 1970 Jun; 19(5):184-6. PubMed ID: 5448541
    [No Abstract]   [Full Text] [Related]  

  • 15. [Concerning: Brunner A., Gartmann J. and Studer H.J.: "Pipoxizin, a new bronchodilator". Schweiz. med. Wschr. 108, 310-2(1978)].
    Schindl R
    Schweiz Med Wochenschr; 1979 Nov; 109(42):1608. PubMed ID: 531549
    [No Abstract]   [Full Text] [Related]  

  • 16. ["Initial experiences with thrombolysis at Swiss hospitals" by H.P. Krayenbühl, H. Ziegler, T. Moccetti and R. Ritz, Schweiz. med. Wschr. 1988; 118: 1695-1697].
    Behrens M; Odavic R
    Schweiz Med Wochenschr; 1989 Feb; 119(6):196. PubMed ID: 2494697
    [No Abstract]   [Full Text] [Related]  

  • 17. [Concerning "The effect of i.v. gamma globulin on T lymphocytes and on interleukin-2 secretionin infectious mononucleosis" by R.E. Martin du Pan, B. Koechli and R.C. Martin du Pan, Schweiz. med. Wschr. 1988; 118: 680-686].
    Martin du Pan RE; Koechli B; Martin du Pan RC
    Schweiz Med Wochenschr; 1988 Dec; 118(51):1962-4. PubMed ID: 2463668
    [No Abstract]   [Full Text] [Related]  

  • 18. [Concerning "How often does thyrostatically treated Basedow's disease recur?" by H. Schleusener et al., Schweiz. med. Wschr. 1990; 120: 769-771].
    Kürzl R
    Schweiz Med Wochenschr; 1990 Sep; 120(38):1406-7. PubMed ID: 1699271
    [No Abstract]   [Full Text] [Related]  

  • 19. [Concerning "risks and benefits of long-term treatment with estrogens" by T.M. Mack and R.K. Ross, Schweiz. med. Wschr. 1989; 119:1811-1820].
    Sitruk-Ware R
    Schweiz Med Wochenschr; 1990 Oct; 120(43):1608-10. PubMed ID: 2251476
    [No Abstract]   [Full Text] [Related]  

  • 20. [Concerning "Hemiparesis and torsades de pointes with low dosage sotalol therapy" by C. Sieber, Ph. Weiss and F. Follath (Schweiz. med. Wschr. 1990; 120: 1397-1399)].
    Liechti M
    Schweiz Med Wochenschr; 1991 Feb; 121(5):160. PubMed ID: 2003213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.